Aurora Cannabis has launched a new product. It is called Black Jelly. This is a high-potency medical cannabis flower. The launch happened in Poland. This expands Aurora’s offerings there. It targets a growing market.
Aurora’s Strong European Presence
Aurora has a long history in Poland. The company first entered the market in 2018. It was one of the first non-government suppliers. Aurora focuses on European medical cannabis markets. Poland is a key region for their strategy. They aim for leadership in high-potency products. This move supports that goal.
Introducing Black Jelly
The new cultivar is named Black Jelly. It is a sativa-dominant hybrid. It boasts a THC content of 27%. CBD levels are less than 1%. The genetics come from Alien Cake 3030 and T037. This strain offers dense flowers. They have green and orange hues. The aroma features sweet black licorice. Fruity undertones are also present. This unique profile comes from Aurora’s breeding program.
Meeting Prescriber and Patient Needs
This new product aims to meet patient demand. Doctors seek reliable, high-potency options. Aurora understands this need. Their advanced genetic breeding program is key. It allows for consistent quality. Black Jelly offers a superior experience. It aligns with patient and prescriber expectations. This is a significant development for medical cannabis news.
A Growing Market Landscape
Poland’s medical cannabis market is expanding. It is one of Europe’s fastest-growing sectors. In 2025, it is the fourth-largest in Europe. Import volumes have increased significantly. Aurora’s expertise helps navigate this market. They have a decade of experience. Navigating complex regulations is their strength. This positions Aurora as a trusted partner.
Quality Through Certified Facilities
Aurora produces Black Jelly in Canada. Their facilities hold GACP and EU-GMP certifications. This ensures premium quality. The company also has EU-GMP facilities in Denmark. These standards are vital for pharmaceutical-grade products. High-quality cultivation techniques are used. This includes premium hang-drying. Careful curing methods are also employed.
Expanding the Portfolio
Black Jelly joins other Aurora products. Farm Gas and Sourdough are already available. They fall under the Cannabis flos Aurora brand. This expansion diversifies patient options. It reflects Aurora’s commitment to innovation. The company also works on new cultivars. Their focus is on science and research.
Future Outlook
Aurora continues to invest in medical cannabis. They aim to improve patient lives. This launch strengthens their international leadership. It supports patient access across Europe. The trend towards high-potency options is clear. Aurora is well-positioned to lead. Their strategic focus benefits the entire cannabis lifestyle. This news highlights their ongoing success.
Aurora’s Commitment to Patients
Aurora’s mission is patient-centric. They are dedicated to providing medical solutions. High-quality products are paramount. This includes both established and novel strains. Black Jelly is a prime example. It offers specific therapeutic benefits. The company believes in cannabis for well-being. This launch reflects that core belief.
A Strategic Market Move
Aurora’s expansion in Poland is strategic. It taps into a rising demand. Their high-potency flower is a key differentiator. This move solidifies their market position. It shows commitment to global growth. The company plans further innovations. Their focus remains on medical cannabis. This trend is key to the evolving cannabis industry.
Summary of Impact
The introduction of Black Jelly is notable. It brings a unique, potent strain to Poland. Aurora’s commitment to quality is evident. Their strategic market approach continues. This development benefits Polish patients. It also reinforces Aurora’s global standing. The company is a key player in trending medical cannabis news.
